Elevation Oncology

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$0
$0
$58
$0
Gross Profit
-4
-10
48
-9
EBITDA
-10,959
-9,859
-7,936
-10,920
EBIT
-10,963
-9,869
-7,946
-10,929
Net Income
-10,461
-10,707
-7,899
-10,636
Net Change In Cash
0
0
58
0
Free Cash Flow
-8,205
-9,575
-12,181
-13,357
Cash
59,447
90,630
49,255
54,878
Basic Shares
59,018
47,371
42,416
42,402

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-39
-27
-18
-15
EBITDA
-40,299
-94,522
-32,028
-17,261
EBIT
-40,338
-94,549
-32,046
-17,276
Net Income
-45,704
-95,080
-32,039
-17,265
Net Change In Cash
0
0
0
0
Cost of Revenue
-100,367
Free Cash Flow
-56,180
-85,569
-30,167
-12,369
Cash
49,255
45,917
146,284
79,400
Basic Shares
34,077
23,267
23,205
23,759

Earnings Calls

Quarter EPS
2024-06-30
-$0.18
2024-03-31
-$0.23
2023-12-31
-$0.19
2023-09-30
-$0.25